| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.001 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |